Dixyrazine

Research use only, not for human use.

Dixyrazine （UCB 3412）has a transient antihypertensive effect, prevents cerebral edema induced by injections of ichthyosperm sulfate, and may be used in the study of neurologically related disorders.

Dixyrazine, a phenothiazine derivative, can prevent brain oedema induced by intracarotid injection of protamine sulphate.

——

Pretreatment with Dixyrazine 10 mg/kg completely prevents the brain oedema and significantly reduces the albumin increase in cerebrospinal fluid (CSF). The phenothiazine Dixyrazine (5 mg/kg i.v.) has minimal, transient hypotensive effects but significantly reduces the leakage of 126I labelled serum albumin in conscious rats subjected to acute hypertension provoked by i.v. Adrenaline or Bicuculline. The diameters of pial arteries and veins are continuously measured with a multichannel videoangiometer through a closed cranial window in anesthetized rats before and after i.v. injection of Dixyrazine (5 mg/kg). Dixyrazine, 5 mg /kg, induces a slight transitory decrease in blood pressure (10-20 mm Hg). Maximum MAP is slightly but not significantly lower in Dixyrazine-treated rats.

——

Others

Other Targets

Others

——

——

2470-73-7

427.6

C24H33N3O2S

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (233.86 mM; Ultrasonic )

CC(CN1CCN(CCOCCO)CC1)CN1c2ccccc2Sc2ccccc12

——

(-20℃)

With Ice Pack

≥ 2 years